Whitehawk Therapeutics, Inc. (WHWK) stock
WHWKNasdaqPharmaceutical PreparationsFiscal year ends December 31
$3.08+0.07 (+2.33%)
Close on Nov 17, 2026Market cap $175.59MP/E –Yield –
Whitehawk Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Whitehawk Therapeutics's enterprise value was -$5.29M on Nov 11, 2026, against -$52.32M a year earlier. Over the last 5 years it ranged from -$152.03M to $342.96M, with a median of $9.71M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$5.29M | – |
| 2025 | Dec 31, 2025 | -$48.55M | -422.4% |
| 2024 | Dec 31, 2024 | $15.06M | – |
| 2023 | Dec 29, 2023 | -$69.76M | -153.7% |
| 2022 | Dec 30, 2022 | $129.99M | -62.1% |
| 2021 | Dec 31, 2021 | $342.96M | – |
| 2020 | Dec 31, 2020 | -$5.73M | – |
| 2019 | Dec 31, 2019 | -$20.61M | – |
| 2018 | Dec 31, 2018 | -$6.71M | -107.4% |
| 2017 | Dec 29, 2017 | $90.84M | – |
| 2011 | Mar 28, 2011 | -$26.45K | – |
See a number that looks wrong?